BETA-LACTAMASE INHIBITOR

European patent · EP3795149 · In force

Register entry

Publication number
EP3795149
Application number
EP19802755
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 14, 2019
Published
Mar 24, 2021
Granted
Sep 30, 2026
Protection ends at the latest
May 13, 2039
Next annual fee due
May 31, 2027
IPC classes
C07D 207/36 (2006.01)
C07D 207/50 (2006.01)
C07D 307/68 (2006.01)
C07D 333/38 (2006.01)
C07D 405/12 (2006.01)
A61K 31/341 (2006.01)
A61K 31/381 (2006.01)
A61K 31/40 (2006.01)
A61P 31/04 (2006.01)
A61P 43/00 (2006.01)
Priority
JP 2018093369 14.05.2018
PCT application
PCT/JP2019/019133 14.05.2019
PCT publication
WO2019/221122 21.11.2019
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 30, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 30.09.2026

Parties

Holder

National University Corporation Tokai National Higher Education and Research System

1, Furo-cho Chikusa-ku, Nagoya-shi Aichi 464-8601, JP

Inventor

ARAKAWA, Yoshichika

Nagoya-shi, Aichi 464-8601, JP

WACHINO, Jun-ichi

Nagoya-shi, Aichi 464-8601, JP

KIMURA, Kouji

Nagoya-shi, Aichi 464-8601, JP

JIN, Wan Chun

Nagoya-shi, Aichi 464-8601, JP

SATO, Ayato

Nagoya-shi, Aichi 464-8601, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.